Does Metronidazole Cover Gram-Negative Organisms?
Metronidazole does NOT provide coverage against gram-negative aerobic or facultative organisms—it is exclusively active against obligate anaerobic bacteria, including gram-negative anaerobes like Bacteroides fragilis group and Fusobacterium species. 1
Understanding Metronidazole's Spectrum
Metronidazole is specifically designed for anaerobic coverage and has no clinically relevant activity against facultative anaerobes or obligate aerobes 1. This is a critical distinction that directly impacts empiric antibiotic selection.
What Metronidazole DOES Cover:
- Anaerobic gram-negative bacilli: Bacteroides species (including B. fragilis group), Fusobacterium species, Prevotella species 1, 2
- Anaerobic gram-positive organisms: Clostridium species, Peptostreptococcus species, susceptible Eubacterium strains 1
- Maintains excellent activity with >90% susceptibility rates against these obligate anaerobes 3, 4
What Metronidazole Does NOT Cover:
- Gram-negative aerobic/facultative organisms: E. coli, Klebsiella, Pseudomonas aeruginosa, Proteus, Enterobacter species
- Gram-positive aerobes: Staphylococcus, Streptococcus, Enterococcus species
- Any organism that can survive in the presence of oxygen
Clinical Implications for Combination Therapy
This is precisely why metronidazole is always combined with other agents when treating polymicrobial infections:
For Intra-Abdominal Infections:
Guidelines consistently recommend metronidazole plus a gram-negative active agent 5, 2, 5:
- Mild-moderate infections: Cefazolin/cefuroxime + metronidazole, or ciprofloxacin/levofloxacin + metronidazole
- Severe infections: Third/fourth-generation cephalosporins + metronidazole, or aztreonam + metronidazole
The rationale is straightforward: intra-abdominal infections contain both facultative gram-negative organisms (E. coli predominates) AND anaerobes (Bacteroides species). Metronidazole handles only the anaerobic component 2, 5.
For Necrotizing Soft Tissue Infections:
Combination regimens include ampicillin (for gram-positives and some facultative gram-negatives) + metronidazole (for anaerobes) + ciprofloxacin or gentamicin (for resistant gram-negative rods) 6.
Common Prescribing Pitfall
Do not use metronidazole monotherapy for any infection involving aerobic or facultative gram-negative bacteria. The drug has zero activity against these organisms despite being a "broad-spectrum" anaerobic agent. When empiric coverage for both aerobes and anaerobes is needed—which is most polymicrobial infections—metronidazole must be paired with an agent active against gram-negative facultative organisms 5, 2.
The FDA label explicitly states metronidazole "does not appear to possess any clinically relevant activity against facultative anaerobes or obligate aerobes" 1. This has remained consistent across decades of use, with recent studies confirming maintained potency against anaerobes but no expansion of spectrum to aerobic organisms 4, 3.